2nd Biosimilar Market Access Strategies Summit – 2nd Biosimilar Market Access Strategies Summit

Featured Speakers

The process of developing a biosimilar and bringing it to market can be a lengthy, expensive process. It is crucial for sponsor organizations to understand the policies that are currently set in order to develop strategies to allow biosimilar drugs to access the marketplace. With a limited number of biosimilars available competition is at an all-time high. However, once you gain approval the real challenge becomes sustaining market success. There is a significant market opportunity ahead for biosimilar developers if they can figure out a strategic plan to enhance the commercialization of the biosimilar.

Whether you are exploring your chances of tapping into the competitive biosimilars marketplace or are an expert in the field, the 2nd Biosimilar Market Access and Commercialization Strategies Summit will provide detailed presentations, intensive case studies and collaborative panel discussions relevant to your interests.

Our talented faculty will address everything from navigating evolving regulations, analyzing optimal pricing models, accelerating market access strategies, and executing strategic decisions to mitigate risk and build for commercial success. Also designated lunches and networking breaks will enhance the exchange of knowledge and foster future business partnerships.

Top Reasons to Attend

  • Discover past, current, and future regulatory standards to develop Biosimilars and bringing them to the market in an efficient manner at a low cost
  • Explore best practices for the commercial structure of a biosimilar from strategy to execution
  • Measure the lack of interchangeability with the reference drugs
  • Appreciate the significance of creating partnerships to successfully establish biosimilar products
  • Explore the challenges of obtaining patents to advance the biosimilar product at a quick rate and a low cost
  • Gain access to case studies for an expert speaking faculty and network with leading drug developers, regulators, and investors

Testimonials

“Very rich knowledge sharing amongst audience and panelists.”
Director, BRISTOL-MYERS SQUIBB

“Exceeded my expectations through networking, quality sessions, and applicability to current work.”
Executive Director, WINDTREE THERAPEUTICS

Who Should Attend

This conference is designed for biotech professionals with responsibilities in the following areas:

  • Biosimilars
  • Biologics/Biotechnology/Biogenerics
  • Biopharmaceuticals/Biotherapeutics
  • Market Access Commercialization
  • Marketing and Sales
  • Strategic/Corporate Planning
  • Pricing and Reimbursement
  • HEOR and Outcomes Research
  • Legal Affairs
  • Intellectual Property
  • Medical Affairs
  • Manufacturing/Bioprocesses
  • Clinical Affairs/Operations/ Development
  • Regulatory Affairs
  • Medical Science Liaisons
  • R&D
  • Quality Control/Assurance

This event is also of interest to:

  • CROs/CMOs/CMDOs
  • Law Firms
  • API Manufacturers
  • Distributors
  • Consulting Companies
  • Market Access Service Providers
  • Licensing Services
  • Distribution and Logistics Services
  • Packaging and Labeling Companies
  • Preclinical/Nonclinical/Analytical Development Research Organizations